AZD7762, a novel checkpoint kinase inhibitor, drives checkpoint abrogation and potentiates DNA-targeted therapies
暂无分享，去创建一个
B. Caleb | G. Schwartz | J. Janetka | G. Walker | S. Ashwell | S. Zabludoff | A. Tse | S. Green | C. Quéva | C. Horn | M. Grondine | A. Sheehy | Dongfang Liu | K. Taylor | H. Haye | E. Mouchet | Shannon Ready | A. White | J. L. Rosenthal | C. Deng